Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR-8068 Combined With Adebrelimab and Chemotherapy in Advanced NSCLC
NCT05416775Phase 2Recruiting
- Sponsor
- Suzhou Suncadia Biopharmaceutical
- Start
- Aug 2022
- Primary completion
- Jun 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of CS1002 in non-small cell lung cancer (NSCLC), sponsored by Suzhou Suncadia Biopharmaceutical. Started Aug 2022; status: recruiting.
02
Drugs
CS1002
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT05416775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05416775.